Sanofi faces $250M charge after J&J-partnered vaccine flunks late-stage testnews2025-02-13T11:47:59+00:00February 13th, 2025|Endpoints News|
Novo’s weight loss drug helps curb some drinking habits, small study showsnews2025-02-12T20:51:49+00:00February 12th, 2025|Endpoints News|
Pfizer wins approval in new indication for blood cancer drug Adcetrisnews2025-02-12T18:23:41+00:00February 12th, 2025|Endpoints News|
AnaptysBio gets a mid-stage win for PD-1 drug in rheumatoid arthritisnews2025-02-12T16:27:09+00:00February 12th, 2025|Endpoints News|
AbbVie pens another T cell engager deal, this time with Xilionews2025-02-12T16:23:42+00:00February 12th, 2025|Endpoints News|
Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesitynews2025-02-12T12:00:25+00:00February 12th, 2025|Endpoints News|
New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitionsnews2025-02-12T09:30:33+00:00February 12th, 2025|Endpoints News|
SpringWorks lands FDA approval for nerve tumor treatmentnews2025-02-12T02:25:12+00:00February 12th, 2025|Endpoints News|
Inventiva cuts pipeline, lays off nearly entire research team in bid to get to Phase 3 MASH readoutnews2025-02-11T14:25:42+00:00February 11th, 2025|Endpoints News|
#ASCOGU: Pfizer’s prostate cancer data leak shows promising results in early-stage studynews2025-02-11T12:24:09+00:00February 11th, 2025|Endpoints News|
